Literature DB >> 1531074

Endothelial cell dysfunction in HIV infection.

A Lafeuillade1, M C Alessi, I Poizot-Martin, C Boyer-Neumann, C Zandotti, R Quilichini, L Aubert, C Tamalet, I Juhan-Vague, J A Gastaut.   

Abstract

We have investigated plasma levels of endothelial cell products playing a role in hemostasis in 125 HIV-positive patients and 30 controls. Antigenic von Willebrand factor increased significantly with disease progression and was closely correlated with CD4+ cell counts and beta 2-microglobulin levels. Tissue-type plasminogen activator was normal in CDC II/III and CDC IVC2 patients and was slightly increased in AIDS patients, whereas plasminogen activator inhibitor was increased in each group, the stage of the disease not having any effect. Mean total protein S levels were lower in HIV-positive patients and, in 27.2% of the cases, were associated with a decrease in free protein S levels. Such abnormalities could be responsible for a hypercoagulable state in these patients and could be explained by endothelial cell damage during HIV infection. Whether this injury is due to HIV itself remains to be further investigated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531074

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  24 in total

Review 1.  Endothelial dysfunction in HIV infection.

Authors:  Bruno R Cotter
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

Review 2.  Thrombotic microangiopathy related to infection in an HIV-positive patient.

Authors:  J Mayo; J Collazos; E Martínez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

3.  Primary pulmonary hypertension and human immunodeficiency virus infection.

Authors:  J Conly; R Hilsden; H Deneer; I Etches; T Moyana
Journal:  Can J Infect Dis       Date:  1997-09

Review 4.  Current update on HIV-associated vascular disease and endothelial dysfunction.

Authors:  Hong Mu; Hong Chai; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

Review 5.  Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapy.

Authors:  Fabrizio D'Ascenzo; Enrico Cerrato; Giuseppe Biondi-Zoccai; Claudio Moretti; Pierluigi Omedè; Filippo Sciuto; Mario Bollati; Maria Grazia Modena; Fiorenzo Gaita; Imad Sheiban
Journal:  Eur Heart J       Date:  2011-12-20       Impact factor: 29.983

6.  Low serum lipoprotein(a) and beta 2-glycoprotein I levels in HIV-1-positive hemophiliacs.

Authors:  J Matsuda; N Saitoh; K Gohchi; M Gotoh; M Tsukamoto
Journal:  Ann Hematol       Date:  1994-06       Impact factor: 3.673

7.  Endothelial function in HIV-infected persons.

Authors:  Anthony Solages; Joseph A Vita; David J Thornton; Jessica Murray; Timothy Heeren; Donald E Craven; C Robert Horsburgh
Journal:  Clin Infect Dis       Date:  2006-03-31       Impact factor: 9.079

8.  Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration.

Authors:  Erik R Kline; Dean J Kleinhenz; Bill Liang; Sergey Dikalov; David M Guidot; C Michael Hart; Dean P Jones; Roy L Sutliff
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

9.  Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system.

Authors:  Denis G Kay; Ping Yue; Zaher Hanna; Serge Jothy; Etienne Tremblay; Paul Jolicoeur
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

Review 10.  Insulin resistance, lipodystrophy and cardiometabolic syndrome in HIV/AIDS.

Authors:  Ovidiu Galescu; Amrit Bhangoo; Svetlana Ten
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.